Stock A, Krumma J, Fleischhack G, Tippelt S, Rink L, Pietsch T
Neuroradiology. 2025; .
PMID: 39960531
DOI: 10.1007/s00234-025-03553-w.
Liu Z, Ren S, Zhang H, Liao Z, Liu Z, An X
Eur Radiol. 2025; .
PMID: 39883158
DOI: 10.1007/s00330-025-11385-8.
Nunes do Espirito Santo D, Warmuth-Metz M, Monoranu C, Hasselblatt M, Thomas C, Pietsch T
Children (Basel). 2025; 12(1.
PMID: 39857913
PMC: 11763948.
DOI: 10.3390/children12010082.
Liu H, Zhang J, Wang Z, Wang W, Han D, Chen X
Cell Rep Med. 2025; 6(1):101914.
PMID: 39809264
PMC: 11866544.
DOI: 10.1016/j.xcrm.2024.101914.
Almousa A, Erjan A, Sarhan N, Obeidat M, Alshorbaji A, Amarin R
Cancers (Basel). 2024; 16(21).
PMID: 39518048
PMC: 11545686.
DOI: 10.3390/cancers16213609.
Central nervous system tumors in adolescents and young adults: A Society for Neuro-Oncology Consensus Review on diagnosis, management, and future directions.
Lim-Fat M, Bennett J, Ostrom Q, Touat M, Franceschi E, Schulte J
Neuro Oncol. 2024; 27(1):13-32.
PMID: 39441704
PMC: 11726256.
DOI: 10.1093/neuonc/noae186.
Molecular and clinical heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcomes: A multicenter cohort study.
Schwalbe E, Lindsey J, Danilenko M, Hill R, Crosier S, Ryan S
Neuro Oncol. 2024; 27(1):222-236.
PMID: 39377358
PMC: 11726341.
DOI: 10.1093/neuonc/noae178.
Long-term outcome of the Milano-hyperfractionated accelerated radiotherapy strategy for high-risk medulloblastoma, including the impact of molecular subtype.
Massimino M, Barretta F, Dossena C, Minasi S, Buttarelli F, Biassoni V
Neuro Oncol. 2024; 27(1):209-218.
PMID: 39331528
PMC: 11726337.
DOI: 10.1093/neuonc/noae189.
Cerebrospinal fluid liquid biopsy by low-pass whole genome sequencing for clinical disease monitoring in pediatric embryonal tumors.
Crotty E, Paulson V, Ronsley R, Vitanza N, Lee A, Hauptman J
Neurooncol Adv. 2024; 6(1):vdae126.
PMID: 39290875
PMC: 11407906.
DOI: 10.1093/noajnl/vdae126.
Proteomic profiling of cerebrospinal fluid reveals TKT as a potential biomarker for medulloblastoma.
Kim J, Choi S, Dan K, Koh E, Ha S, Phi J
Sci Rep. 2024; 14(1):21053.
PMID: 39251709
PMC: 11383936.
DOI: 10.1038/s41598-024-71738-z.
Diagnosis of pediatric central nervous system tumors using methylation profiling of cfDNA from cerebrospinal fluid.
Cornelli L, Van Paemel R, Ferro Dos Santos M, Roelandt S, Willems L, Vandersteene J
Clin Epigenetics. 2024; 16(1):87.
PMID: 38970137
PMC: 11225235.
DOI: 10.1186/s13148-024-01696-w.
Neurosurgical short-term outcomes for pediatric medulloblastoma patients and molecular correlations: a 10-year single-center observation cohort study.
Zhang Z, Wu Y, Zhao X, Ji W, Li L, Zhai X
Neurosurg Rev. 2024; 47(1):283.
PMID: 38904885
DOI: 10.1007/s10143-024-02526-6.
Effective re-induction regimen for children with recurrent medulloblastoma.
OHalloran K, Phadnis S, Friedman G, Metrock K, Davidson T, Robison N
Neurooncol Adv. 2024; 6(1):vdae070.
PMID: 38863988
PMC: 11165644.
DOI: 10.1093/noajnl/vdae070.
Imaging in malignant germ cell tumors involving the hypothalamo-neurohypophyseal axis: the evaluation of the posterior pituitary bright spot is essential.
Stock A, Calaminus G, Weisthoff M, Serfling J, Pietsch T, Bison B
Neuroradiology. 2024; 66(8):1405-1416.
PMID: 38844695
PMC: 11246258.
DOI: 10.1007/s00234-024-03384-1.
Human-Level Differentiation of Medulloblastoma from Pilocytic Astrocytoma: A Real-World Multicenter Pilot Study.
Wiestler B, Bison B, Behrens L, Tuchert S, Metz M, Griessmair M
Cancers (Basel). 2024; 16(8).
PMID: 38672556
PMC: 11048511.
DOI: 10.3390/cancers16081474.
Treatment response as surrogate to predict risk for disease progression in pediatric medulloblastoma with persistent magnetic resonance imaging lesions after first-line treatment.
Obrecht-Sturm D, Schomig L, Mynarek M, Bison B, Schwarz R, Pietsch T
Neuro Oncol. 2024; 26(9):1712-1722.
PMID: 38578306
PMC: 11376455.
DOI: 10.1093/neuonc/noae071.
Existing and Evolving Landscape of Medulloblastoma: Towards Optimization and Personalization.
Gupta T, Chatterjee A
Diagnostics (Basel). 2024; 14(6).
PMID: 38535019
PMC: 10969555.
DOI: 10.3390/diagnostics14060598.
The anatomic basis of leptomeningeal metastasis.
Freret M, Boire A
J Exp Med. 2024; 221(4).
PMID: 38451255
PMC: 10919154.
DOI: 10.1084/jem.20212121.
The clinical significance of sub-total surgical resection in childhood medulloblastoma: a multi-cohort analysis of 1100 patients.
Keeling C, Davies S, Goddard J, Ramaswamy V, Schwalbe E, Bailey S
EClinicalMedicine. 2024; 69:102469.
PMID: 38374970
PMC: 10875250.
DOI: 10.1016/j.eclinm.2024.102469.
Evolution of Systemic Therapy in Medulloblastoma Including Irradiation-Sparing Approaches.
Mushtaq N, Ul Ain R, Hamid S, Bouffet E
Diagnostics (Basel). 2023; 13(24).
PMID: 38132264
PMC: 10743079.
DOI: 10.3390/diagnostics13243680.
